Table 4. Clinical factors and symptom burden associated with PHC utilisation (n = 213).
| Variable | PHC use Yes (Count, %) |
PHC use No (Count, %) |
p —value |
|---|---|---|---|
| Stage | 0.000 | ||
| I–II | 39 (92.9%) | 3 (7.1%) | |
| III–IV | 108 (63.2%) | 63 (36.8%) | |
| Surgery | 0.885 | ||
| No | 110 (68.8%) | 50 (31.3%) | |
| Yes | 37 (69.8%) | 16 (30.2%) | |
| ADT | 0.022 | ||
| No | 44 (81.5%) | 10 (18.5%) | |
| Yes | 103 (64.8%) | 56 (35.2%) | |
| Chemotherapy | 0.932 | ||
| No | 90 (69.2%) | 40 (30.8%) | |
| Yes | 57 (68.7%) | 26 (31.3%) | |
| Hypertension | 0.007 | ||
| No | 100 (75.8%) | 32 (24.2%) | |
| Yes | 47 (58.0%) | 34 (42.0%) | |
| Diabetes | 0.305 | ||
| No | 121 (67.6%) | 58 (32.4%) | |
| Yes | 26 (76.5%) | 8 (23.5%) | |
| Back/Joint pain | 0.118 | ||
| No | 38 (61.3%) | 24 (38.7%) | |
| Yes | 109 (72.2%) | 42 (27.8%) | |
| HIV status | 0.314 | ||
| No | 128 (70.3%) | 54 (29.7%) | |
| Yes | 19 (61.3%) | 12 (38.7%) | |
| Urinary symptoms | 0.004 | ||
| Normal/moderate | 66 (80.5) | 16 (19.5) | |
| Severe/Quite often | 81 (61.8) | 50 (38.2) | |
| Bowel symptoms | 0.84 | ||
| Normal/moderate | 137 (68.8) | 62 (31.2) | |
| Severe/Quite often | 10 (71.4) | 4 (28.6) | |
| Treatment symptoms | <0.001 | ||
| Normal/moderate | 50 (55.6) | 40 (44.4) | |
| Severe/Quite often | 97 (78.9) | 26 (21.1) | |
| Sexual symptoms | |||
| Normal/moderate | 53 (55.8) | 42 (44.2) | |
| Severe/Quite often | 94 (79.7) | 24 (20.3) | <0.001 |
| ADT, Androgen Deprivation Therapy; HIV, Human Immunodeficiency Virus | |||